Met-Hb and inflammation markers with tumescence local anaesthesia (TLA)

Completed

• Conditions: Tumescence local anaesthesia (TLA)/established anaesthesia techniques; Signs and Symptoms; Anaesthesia techniques

• Registration Number: ISRCTN19821978
• Lead Sponsor: niversity Clinic Mannheim (Germany) - Department of Anaesthesiology and Critical Care Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-03-20
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Patients (male/female) with operations which are performed in TLA with prilocaine
2. Age: 18 - 85 years
3. American Society of Anaesthesiologists (ASA) grade I - III
4. No allergy against prilocaine

Exclusion Criteria

1. Allergy against prilocaine
2. Pregnancy
3. Patient denies operation in TLA

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Met-Hb-concentration over the time, measured over 48 hours.

Secondary Outcome Measures

Name	Time	Method
Elevation of inflammation markers, measured over 48 hours.